Mr Hatanaka assumed CEO of Yamanouchi Europe in 2003. In this time, he directed 16 companies engaged in manufacturing, development and sales in Europe and successfully accomplished launching 3 new drugs in the urologic treatment field.

In 2005-6, after assuming the role of Senior Advisor of Astellas Pharma Europe, Mr Hatanaka returned to Japan in April, 2006. Was named Operating Officer of Astellas Pharma Inc.

Hatanaka Pharma Consulting Co, Ltd. was established in July 2006. The primary purpose of the business is to;
1. Contribute to innovation of operation of pharmaceutical businesses,
2. Support alliances between Japanese pharmaceutical businesses and U.S. or European pharmaceutical businesses from a global standpoint.

Mr Hatanaka will take advantage of ample experiences of business operations in Japan and experiences of management obtained in the overseas assignments.

Previous career history:

In 1968, Mr. Hatanaka joined Yamanouchi Pharmaceutical Co., Ltd. Until 1992, served as a front line MR and Director of Sales Office, and thereafter moved to the Corporate Marketing & Sales Department to fulfill responsibilities to develop and drive hospital strategies and university fostering strategies as well as CRM for 2 years. Assumed the position of Director of Hiroshima District Office and then Osaka District Office for a period of 1994 through 2001.

In 2001, assumed the Director of Board and General Manager of Pharmaceutical Sales & Marketing responsible for the sales and marketing organization for Japan. Contributed to establishing powerful sales force which enabled Yamanouchi to increase the share of market up to the second place in the domestic market.

In 2002, assumed the Director of Board responsible for global sales and marketing for USA, Europe and Asia; project to establish framework of direct sales in the U.S.; project to promote global pre-marketing of Vesicare product.